12-[2-(Ethyl-propyl-amino)-ethyl]-2,3-dimethoxy-12H-8,10-dioxa-6,12-diaza-cyclopenta[b]chrysen-13-one

ID: ALA540712

PubChem CID: 11155484

Max Phase: Preclinical

Molecular Formula: C26H29N3O5

Molecular Weight: 463.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(CCn1c(=O)c2cc(OC)c(OC)cc2c2cnc3cc4c(cc3c21)OCO4)C(C)C

Standard InChI:  InChI=1S/C26H29N3O5/c1-6-28(15(2)3)7-8-29-25-18-11-23-24(34-14-33-23)12-20(18)27-13-19(25)16-9-21(31-4)22(32-5)10-17(16)26(29)30/h9-13,15H,6-8,14H2,1-5H3

Standard InChI Key:  OEDTUCGXUBRFNL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
    0.0625   -0.3125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0625    0.5208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6583   -0.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6583    0.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3625    0.5208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3625   -0.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7792    0.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7792    1.7583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4917    0.5208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0833    0.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0833   -0.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0542    2.1708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6583    1.7583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7792   -0.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4917    2.1708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2125    0.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2125    1.7583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8000    0.5208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8000   -0.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6583   -1.5500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9917    0.6833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9917    2.0208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4792    1.3458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4917   -1.9750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7792   -1.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4917   -2.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5208    0.9458    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5208   -0.7375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1917   -1.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1917   -3.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7792   -3.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2375    0.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2375   -0.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1917   -0.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  2  0
  5  6  1  0
  6  3  1  0
  7  2  1  0
  8  7  2  0
  9  7  1  0
 10  5  2  0
 11  6  2  0
 12  8  1  0
 13  4  1  0
 14  1  1  0
 15  8  1  0
 16  9  2  0
 17 16  1  0
 18 19  2  0
 19 11  1  0
 20  3  2  0
 21 16  1  0
 22 17  1  0
 23 21  1  0
 24 25  1  0
 25 14  1  0
 26 24  1  0
 27 18  1  0
 28 19  1  0
 29 24  1  0
 30 26  1  0
 31 26  1  0
 32 27  1  0
 33 28  1  0
 34 29  1  0
  5  4  1  0
 12 13  2  0
 18 10  1  0
 17 15  2  0
 23 22  1  0
M  END

Associated Targets(Human)

RPMI 8402 (281 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB 3-1 (1143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 463.53Molecular Weight (Monoisotopic): 463.2107AlogP: 4.18#Rotatable Bonds: 7
Polar Surface Area: 75.05Molecular Species: BASEHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.99CX LogP: 3.22CX LogD: 1.62
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.38Np Likeness Score: -0.64

References

1. Ruchelman AL, Houghton PJ, Zhou N, Liu A, Liu LF, LaVoie EJ..  (2005)  5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.,  48  (3): [PMID:15689163] [10.1021/jm049447z]
2. Zhou W, Dai Z, Chen Y, Yuan Z.  (2013)  Computational QSAR models with high-dimensional descriptor selection improve antitumor activity design of ARC-111 analogues,  22  (1): [10.1007/s00044-012-0034-x]

Source